Dr. Mikhitarian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Hampton Rd
Unit 200
Exeter, NH 03833
Education & Training
- Vanderbilt University Medical Center Renal PathologyFellowship, Selective Pathology, 2011 - 2012
- University of Michigan Health System Surgical PathologyFellowship, Selective Pathology, 2010 - 2011
- University of Missouri-ColumbiaResidency, Pathology-Anatomic and Clinical, 2006 - 2010
- Tartu State University - Institute of MedicineClass of 1998
Certifications & Licensure
- ME State Medical License 2017 - 2026
- KS State Medical License 2012 - 2025
- MO State Medical License 2012 - 2025
- NH State Medical License 2017 - 2025
- TN State Medical License 2011 - 2022
- MI State Medical License 2010 - 2020
- NE State Medical License 2016 - 2016
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
Publications & Presentations
PubMed
- 410 citationsEpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy.Walid Osta, Yian Chen, Kaidi Mikhitarian, Michael Mitas, Mohamed L. Salem
Cancer Research. 2004-08-15 - 37 citationsProstate-Specific Ets ( PSE ) factor: a novel marker for detection of metastatic breast cancer in axillary lymph nodesMichael Mitas, Kaidi Mikhitarian, Loretta Hoover, M A Lockett, L Kelley
British Journal of Cancer. 2002-03-18 - 51 citationsLunx Is a Superior Molecular Marker for Detection of Non-Small Lung Cell Cancer in Peripheral BloodMichael Mitas, Loretta Hoover, Gerard A. Silvestri, Carolyn E. Reed, Mark R. Green
The Journal of Molecular Diagnostics. 2003-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: